HAE
Haemonetics Corporation
NYSE · Healthcare · Medical - Instruments & Supplies · US
$102.92
+0.07%Margins
Gross margin
57.4%
EBITDA margin
19.3%
EBIT margin
18.2%
Net margin
7.1%
FCF margin
21.5%
11.5%
Return on equity
4.1%
Return on assets
12.2%
Return on invested capital
0.57x
Asset turnover
$328.1M
Cash from operations
$4.91
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026